What does BlossomHill Therapeutics, Inc. do?
BlossomHill Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops small molecule medicines that address medical needs in cancer treatment. Its pipeline includes BH-30643, an OMNI-EGFR inhibitor in clinical development for advanced EGFR-mutant non-small cell lung cancer (NSCLC), BH-501284, and…
What is BlossomHill Therapeutics, Inc.'s P/E and P/B ratio?
BlossomHill Therapeutics, Inc. has a P/E ratio of -3.4 and a P/B ratio of -2.88.
What is BlossomHill Therapeutics, Inc.'s debt-to-equity ratio?
BlossomHill Therapeutics, Inc. has a debt-to-equity ratio of 0.28.
How much does BlossomHill Therapeutics, Inc. owe compared with what it owns?
BlossomHill Therapeutics, Inc. owes $2.41 for every $1 it owns (balance sheet Jun 2026), which means it owes more than it owns.
What is BlossomHill Therapeutics, Inc.'s Positivity rank?
BlossomHill Therapeutics, Inc. is ranked #6,454 of 6,774 companies globally and #3,711 of 4,000 in United States on PositoAI, with a Positivity Score of -20,042.
Does BlossomHill Therapeutics, Inc. have any regulatory orders, red flags (PosiRed) or yellow flags (PosiYellow)?
No active red flags (PosiRed) or yellow flags (PosiYellow) are currently on record for BlossomHill Therapeutics, Inc..
Where can I read the latest news about BlossomHill Therapeutics, Inc.?
Recent headlines about BlossomHill Therapeutics, Inc. from the last 30 days, with links to the original articles, are on its News page on PositoAI.
Does BlossomHill Therapeutics, Inc. have a PositoAI PosiShot or QR code?
Yes. A dated PosiShot of BlossomHill Therapeutics, Inc.'s current position, a PosiQR code for its live profile and a ready-made dated mention are available on its For this company page on PositoAI.